Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Friedreich Ataxia is a neuro-cardiodegenerative disease caused by the deficiency of frataxin, a mitochondrial protein. Many evidences indicate that frataxin deficiency causes an unbalance of iron homeostasis. Nevertheless, in the last decade many results also highlighted the importance of calcium unbalance in the deleterious downstream effects caused by frataxin deficiency. In this review, the role of these two metals has been gathered to give a whole view of how iron and calcium dyshomeostasys impacts on cellular functions and, as a result, which strategies can be followed to find an effective therapy for the disease.

More information Original publication

DOI

10.1002/iub.2457

Type

Journal article

Publication Date

2021-03-01T00:00:00+00:00

Volume

73

Pages

543 - 553

Total pages

10

Keywords

Friedreich ataxia, calcium, iron, mitochondrial disorders, Calcium, Friedreich Ataxia, Homeostasis, Humans, Iron, Iron Chelating Agents, Iron-Binding Proteins, Mitochondria, Frataxin